A high-throughput screening dataset of small-molecule inhibitors across human DNA glycosylases
Authors:
Preprint
Abstract
The base excision repair pathway removes small base lesions from DNA and is initiated in humans by one of eleven DNA glycosylases with overlapping substrate specificities. Despite their central role in genome maintenance and transcription, systematic datasets describing small-molecule binders or inhibitors of DNA glycosylases are lacking. Here, through a collaborative effort across Scandinavia, we establish a high-throughput biochemical assay platform for human DNA glycosylases and use it to generate a systematic small-molecule screening dataset. A chemogenomic library was screened against nine glycosylases with assays of sufficient quality for hit identification, yielding primary screening and concentration-response data and identifying multiple previously unreported inhibitors. All primary and processed data, along with detailed assay protocols and metadata, are publicly available to support reuse in chemical biology, further compound optimization, assay development and comparative studies of DNA repair enzymes. Abstract Figure:Keywords
Funding Information
- Innovative Health Initiative (875510)
This publication has 36 references indexed in Scilit:
- A monofunctional-like mutant of DNA glycosylase NTHL1 changes the dynamics of DNA repair during acute oxidative stressJournal of Biological Chemistry, 2026
- Giving an Enzyme Scissors: Serotonin Derivatives as Potent Organocatalytic Switches for DNA Repair Enzyme OGG1Journal of Medicinal Chemistry, 2025
- Modulation of OGG1 enzymatic activities by small molecules, promising tools and current challengesDNA Repair, 2025
- Small-molecule activator of SMUG1 enhances repair of pyrimidine lesions in DNADNA Repair, 2025
- Optimization of N‐Piperidinyl‐Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8‐Oxo‐Guanine DNA Glycosylase 1ChemMedChem, 2022
- Theory and applications of differential scanning fluorimetry in early-stage drug discoveryBiophysical Reviews, 2020
- Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy VolunteersClinical Drug Investigation, 2019
- Targeting BER enzymes in cancer therapyDNA Repair, 2018
- Human NEIL3 is mainly a monofunctional DNA glycosylase removing spiroimindiohydantoin and guanidinohydantoinDNA Repair, 2013
- 8-Oxoguanine-DNA glycosylase 1 deficiency modifies allergic airway inflammation by regulating STAT6 and IL-4 in cells and in miceFree Radical Biology and Medicine, 2012